This paper was originally published by Martin Schiestl, Markus Zabransky, and Fritz Sörgel in Drug Des Devel Ther. 2017; 11: 1509–1515 under […]
Ten years of biosimilars in Europe: development and evolution of the regulatory pathways Read Post »
What can we build for you? Do you have special business intelligence needs? Let us apply our industry expertise and
Make better decisions with advanced biopharmaceutical business intelligence Read Post »
The Current Landscape of Drug Innovation The pharmaceutical industry stands at a crossroads, facing unprecedented challenges and opportunities. With the
Drug repositioning has emerged as a powerful strategy to breathe new life into existing medications. This innovative approach, also known
Review of Drug Repositioning Approaches and Resources Read Post »
This paper was originally published by Glenn P. Carroll, Sanjay Srivastava, Adam S. Volini, Marta M. Piñeiro-Núñez, and TatianaVetman in Drug Discovery
Measuring the effectiveness and impact of an open innovation platform Read Post »
The story of Viagra’s patents and generic entry of sildenafil citrate is a valuable one because it covers many of
Viagra: A Complicated Case Study of Generic Drug Market Entry in the United States Read Post »
Drugs can have many patents and regulatory protections Drugs can be covered by myriad patents and regulatory protections. Even Aspirin,
The Rise of Biosimilars in Asia Biosimilars have been making waves across the globe, but nowhere is their impact more
The Rise of China’s Pharmaceutical Industry China’s pharmaceutical industry has undergone a remarkable transformation in recent years. From being primarily
China and Potential Opportunity for Pharmaceutical Investments Read Post »
Get fresh news and insights, drug patent expirations & more…
